BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 12, 2019
View Archived Issues
A specific CNOT1 mutation results in impaired pancreatic and neurological development
Read More
Bacteriophages have "cascading effects" on microbiome
Read More
Clogged (nuclear) pores lead to febrile encephalopathy
Read More
First-in-human data presented for the nanotherapeutic compound NU-0129
Read More
Preliminary results from phase I study of MORAb-202 in patients with FRA-positive solid tumors
Read More
Clinical data show potential for improved renal transplant outcomes with CFZ-533
Read More
Deciphera adds first-in-class autophagy inhibitor to pipeline
Read More
Phase II data presented for NS-0200 in obesity
Read More
VTS-270 does not show efficacy in phase II/III study in type C Niemann-Pick disease
Read More
Eli Lilly initiates phase I study of its bispecific antibody LY-3434172
Read More
FDA approves Keytruda for two new indications
Read More
FDA clears IND for Sleeping Beauty TCR-T-cell therapy trial
Read More
Pharming initiates phase I/II study of Ruconest in patients with pre-eclampsia
Read More
Topline 12-week data reported from an ongoing phase IIb study of seladelpar in NASH
Read More
Sanofi presents preliminary data from a first-in-human study of SAR-439859
Read More
NT-1195, a potential treatment for type 2 diabetes, shows promising preclinical results
Read More
Immunicum reports partial responses in phase I/II trial of ilixadencel in GIST
Read More
Bristol-Myers Squibb patents TYK2 inhibitors
Read More
Evestra divulges LIF and MDM2 inhibitors
Read More
Tenebio opens enrollment in phase I study of TNB-383B in relapsed or refractory multiple myeloma
Read More
Bayer and and The Broad Institute present MCL1 inhibitors
Read More
DKFZ and Bayer identify AhR antagonists
Read More
CuroGene Life Sciences divulges recombinant vectors for macular degeneration
Read More
Gut microbe enzymes can convert blood from type A to type O
Read More
BARDA contract supports Mapp's development of MBP-091 for Marburg virus
Read More
